Menu Back toWelcome-Message

Accelerating Access to Innovative Products – Improving Responses to Pandemic Diseases

Welcome Message


Joseph  Scheeren, PharmD

Joseph Scheeren, PharmD

  • President and CEO
  • Critical Path Institute (C-Path), United States
John CW Lim, MD, MSc

John CW Lim, MD, MSc

  • Professor Duke-NUS CoRE, Consortium for Clinical Research & Innovation Singapore
  • Duke-NUS CoRE, Singapore

Contact us